An experimental approach that has shown promise in animal models of mitochondrial disease is the general induction of mitochondrial biogenesis, achieved for example by activating the key energy sensor and metabolic regulator, the AMP‐activated protein kinase (AMPK) [3, 4]. The gene discussed is PRKAA1; the disease is inborn mitochondrial metabolism disorder.